Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.72
+1.55 (10.18%)
Nov 9, 2026, 3:11 PM EST - Market open

Greenwich LifeSciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
245291148135195319
Market Cap Growth
111.57%97.19%9.21%-30.79%-38.84%-31.08%
Enterprise Value
236287142126180290
Last Close Price
15.1721.0111.2310.5215.2024.33

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
71.44824.09162.4620.1714.7811.90
P/TBV Ratio
79.02824.09162.7820.1914.7911.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.85-17.49-4.50-1.04-1.02-1.01
Net Debt / EBITDA Ratio
0.390.320.230.751.685.92
Quick Ratio
1.541.061.2923.7451.2370.63
Current Ratio
1.541.061.2923.7451.2370.63
Return on Equity (ROE)
-986.32%-3068.25%-457.73%-89.30%-39.08%-16.78%
Return on Assets (ROA)
-235.98%-236.67%-198.82%-56.95%-24.70%-10.28%
Return on Capital Employed (ROCE)
-726.90%-5505.90%-1941.10%-139.20%-60.80%-17.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.44%-6.65%-11.80%-6.58%-4.01%-1.43%
Buyback Yield / Dilution
-7.79%-4.00%-1.29%0.51%0.23%-36.27%
SEC Filings: 10-K · 10-Q